Molecular analysis for refractory rare cancers: Sequencing battle continues - learnings for the MOSCATO-01 study.
Fiche publication
Date publication
novembre 2022
Journal
Critical reviews in oncology/hematology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MALOUF Gabriel, Dr VIGNOT Stéphane
Tous les auteurs :
Debien V, Vignot S, Massard C, Malouf G, Hollebecque A, Scoazec JY, Michiels S, Verlingue L
Lien Pubmed
Résumé
For patients with metastatic rare cancers, treatments are limited. How systematic tumor sequencing can improve therapeutic possibilities in this population?
Mots clés
Early phases, Molecular screening, Precision medicine, Rare cancer, Targeted therapy
Référence
Crit Rev Oncol Hematol. 2022 11 29;181:103888